TapImmune Inc. is a public OTC-BB biotechnology company with its core business focus on emerging technologies based on cellular immunology and genetic understanding of the cause and potential novel treatments of disease.

TapImmune Video

Financial Statements

Fiscal Year 2009

Form 10-QSB Third Quarter Report
Form 10-QSB Second Quarter Report
Form 10-QSB First Quarter Report

Fiscal Year 2008

Form 10-KSB Annual Report
Form 10-QSB Third Quarter Report
Form 10-QSB Second Quarter Report
Form 10-QSB First Quarter Report

Click here for a list of all previous filings

		Corporate Snapshot